Publication
Gene therapy products in Canada
In recent years, the incredible promise of gene therapy has become a reality as multiple gene therapy products have come to market.
Marjorie Glover, David Gallai and Rachel Kurth write a monthly column in the Employee Benefit Plan Review providing expert insight into employee benefits questions. This month's article addresses questions concerning top-hat plans and claims procedures, differences between ERISA bonds and ERISA fiduciary insurance and counting interns for ACA purposes.
Publication
In recent years, the incredible promise of gene therapy has become a reality as multiple gene therapy products have come to market.
Subscribe and stay up to date with the latest legal news, information and events . . .
© Norton Rose Fulbright LLP 2023